Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1α, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal CancerLei Xu, Gregory Y. Lauwers, Rekha Samuel et al.|Cancer Research|2009Cited by 161
Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer modelsMyrofora Panagi, Triantafyllos Stylianopoulos, Fotios Mpekris et al.|Nature Communications|2022Cited by 109
Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano‐immunotherapy in Breast Cancer Lung MetastasisFotios Mpekris, Triantafyllos Stylianopoulos, Myrofora Panagi et al.|Advanced Science|2020Cited by 106